5700-56-1

Basic information

• Product Name: 1-PHENYL-ETHANE-1,2-DIAMINE
• Synonyms: 1-PHENYL-ETHANE-1,2-DIAMINE;1-Phenyl-1,2-diaminoethane;1-Phenyl-1,2-ethanediamine
• CAS NO: 5700-56-1
• Molecular Formula: C₈H₁₂N₂
• Molecular Weight: 136.19
• Mol File: 5700-56-1.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 262.6 °C at 760 mmHg
• Flash Point: 132.3 °C
• Appearance: /
• Density: 1.044 g/cm³
• Vapor Pressure: 0.0108mmHg at 25°C
• Refractive Index: 1.571
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-PHENYL-ETHANE-1,2-DIAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-PHENYL-ETHANE-1,2-DIAMINE(5700-56-1)
• EPA Substance Registry System: 1-PHENYL-ETHANE-1,2-DIAMINE(5700-56-1)

Safety Data

• Hazardous Substances Data: 5700-56-1(Hazardous Substances Data)

Usage

General Description

1-Phenyl-Ethane-1,2-Diamine is a chemical compound that falls under the category of aliphatic amines and it is used predominantly as an organic intermediate in the production of pharmaceuticals, agrochemicals, and dyestuffs. Its molecular formula is C8H12N2 and its molecular weight is 136.193 g/mol. 1-PHENYL-ETHANE-1,2-DIAMINE is characterized by its clear colorless to light yellow liquid form at standard temperature and pressure. It possesses moderately strong basic properties. Moreover, it is slightly soluble in water and other polar solvents. Caution is advised while handling this chemical as it can cause skin and eye irritation upon contact, respiratory irritation upon inhalation, and may be harmful if swallowed.

InChI:InChI=1/C8H12N2/c9-6-8(10)7-4-2-1-3-5-7/h1-5,8H,6,9-10H2

Upstream product

• 7707-64-4 3-phenyl-furazan 5-oxide 
• 28236-68-2 3-phenyl-furazan 2-oxide 
• 64-17-5 ethanol 
• 17016-15-8 anti-phenylglyoxime 
• 825-52-5 2-(hydroxyimino)-2-phenylacetonitrile 
• 4589-97-3 phenylglyoxime 
• 16750-42-8 2-amino-2-phenylacetonitrile 
• 700-63-0 Phenylglycinamid 
• 27129-49-3 4-phenylimidazolidin-2-one 
• 22710-73-2 1,2-diazido-1-phenylethane 
• 53641-61-5 1-phenyl-1-acetylamino-2-acetylaminoethane 
• 28438-00-8 2-methyl-4-phenyl-4,5-dihydro-imidazole-1-carboxylic acid amide 
• 142563-73-3 (Z)-2-azido-1-phenylethanone O-methyloxime 
• 7647-01-0 hydrogenchloride 

Downstream Products

• 62779-70-8 (1S)-1-phenylethylene-1,2-diamine 
• 62779-69-5 (R)-1,2-Diamino-1-phenylethane 
• 53641-61-5 1-phenyl-1-acetylamino-2-acetylaminoethane 
• 95006-06-7 N,N'-(phenyl-ethanediyl)-bis-benzamide 
• 16670-17-0 (1-phenyl-ethanediyldiimino)-tetra-acetic acid 
• 66042-89-5 2,5,6-triphenyl-2,3-dihydro-pyrazine 
• 859798-47-3 2-phenyldibenzo[f,h]quinoxaline 
• 28438-04-2 2-methyl-4-phenyl-4,5-dihydro-1⁽³⁾H-imidazole 
• 61796-78-9 Undec-10-enoic acid (1-phenyl-2-undec-10-enoylamino-ethyl)-amide 
• 61796-88-1 2-Ethyl-N-[2-(2-ethyl-butyrylamino)-1-phenyl-ethyl]-butyramide 
• 4057-62-9 3-phenyl-1,2,5-thiadiazole 
• 33710-58-6 3-amino-4-phenyl-1,2,5-thiadiazole 
• 49704-08-7 4-phenyl-4,5-dihydro-1H-imidazol-2-thione 
• 79592-40-8 (6R,7R)-3-Methyl-8-oxo-7-(4-phenyl-4,5-dihydro-1H-imidazol-2-ylamino)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester 

Relevant articles and documents

Palladium-Catalyzed Intermolecular Oxidative Diazidation of Alkenes

A palladium-catalyzed oxidative vicinal diazidation of alkenes has been developed, in which TMSN3 was used as azide source. Both styrenes and unactivated alkenes are suitable for this reaction. And trans-alkyldiazides were obtained as major products from cyclic alkenes with moderate to good diastereoselectivities. This reaction afforded an efficient way for the synthesis of useful 1,2-diamines after hydrogenation.

One-pot protocol to synthesize N-(β-nitro)amides by tandem Henry/Ritter reaction

A novel, efficient and atom economical one pot protocol for the synthesis of N-(β-nitro)amides has been described by combining the Henry reaction with the Ritter reaction. The designed products could be obtained from easily available aldehydes, nitroalkan

COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USES AS IDH1 MUTANTS INHIBITORS FOR TREATING CANCERS

Provided are compounds of formula (I), wherein X, Y, Z, W, V, R2, R3 and m are defined as in the description. Their pharmaceutical compositions and their uses as IDH1 mutants inhibitors for treating cancers are also provided